SEROTONERGIC COMPONENT OF NEUROLEPTIC RECEPTORS

[1] ANDEN NE, 1971, J PHARMACOL EXP THER, V179, P236

[2] ASOMS C, 1977, ACTA PSYCHIATR SCAND, V55, P116

[3] BENNETT JP, 1976, MOL PHARMACOL, V12, P373

[4] DOPAMINE RECEPTOR-BINDING IN CORPUS STRIATUM OF MAMMALIAN BRAIN [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (11) : 4655 - 4659

[5] Colpaert F C, 1976, Int Rev Neurobiol, V19, P225, DOI 10.1016/S0074-7742(08)60705-9

[6] DOPAMINE RECEPTOR-BINDING - DIFFERENTIATION OF AGONIST AND ANTAGONIST STATES WITH H-3-DOPAMINE AND HALOPERIDOL-H-3 [J]. LIFE SCIENCES, 1975, 17 (06) : 993 - 1001

[7] Deberdt R, 1976, Acta Psychiatr Belg, V76, P157

[8] ENNA SJ, 1976, NATURE, V263, P339

[9] JANSSEN PAJ, 1968, ARZNEI-FORSCHUNG, V18, P261

[10] JANSSEN PAJ, 1975, ARZNEIMITTEL-FORSCH, V25, P1287

[1] ANDEN NE, 1971, J PHARMACOL EXP THER, V179, P236

[2] ASOMS C, 1977, ACTA PSYCHIATR SCAND, V55, P116

[3] BENNETT JP, 1976, MOL PHARMACOL, V12, P373

[4] DOPAMINE RECEPTOR-BINDING IN CORPUS STRIATUM OF MAMMALIAN BRAIN [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (11) : 4655 - 4659

[5] Colpaert F C, 1976, Int Rev Neurobiol, V19, P225, DOI 10.1016/S0074-7742(08)60705-9

[6] DOPAMINE RECEPTOR-BINDING - DIFFERENTIATION OF AGONIST AND ANTAGONIST STATES WITH H-3-DOPAMINE AND HALOPERIDOL-H-3 [J]. LIFE SCIENCES, 1975, 17 (06) : 993 - 1001

[7] Deberdt R, 1976, Acta Psychiatr Belg, V76, P157

[8] ENNA SJ, 1976, NATURE, V263, P339

[9] JANSSEN PAJ, 1968, ARZNEI-FORSCHUNG, V18, P261

[10] JANSSEN PAJ, 1975, ARZNEIMITTEL-FORSCH, V25, P1287